The NEU-STIM Trial

Sponsor
Leiden University Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05942924
Collaborator
European Society for Paediatric Research (Other)
3,280
5
2
20
656
32.8

Study Details

Study Description

Brief Summary

The aim of this study is to determine the effect of repetitive tactile stimulation compared to selective stimulation on oxygenation of the infant at 5 minutes after birth. Infants born before 32 weeks of gestation will be included in this trial. This is a stepped-wedge cluster randomised controlled trial. The participating centre, rather than the individual infant, will be the unit of randomisation. This design is appropriate to test the effect of an intervention that encompasses a behavioral aspect - in this case the performance of tactile stimulation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Repeated tactile stimulation
  • Procedure: Selective tactile stimulation
N/A

Detailed Description

Rationale: A randomised study demonstrated that preterm infants who received repetitive stimulation at birth (10 second episodes of stroking of the soles of the feet and/or back, followed by 10 seconds rest) showed an increase in respiratory effort. This may in turn improve clinical outcomes as improved breathing effort may reduce the need for invasive respiratory support. Tactile stimulation can be immediately and easily performed at birth at no extra cost. It therefore has great potential to be implemented in delivery rooms (DRs) worldwide.

Objective: To determine the effect of repetitive tactile stimulation compared to selective stimulation on oxygenation of the infant at 5 minutes after birth.

Study design: This is a stepped-wedge cluster randomised controlled trial. The participating centre, rather than the individual infant, will be the unit of randomisation. This design is appropriate to test the effect of an intervention that encompasses a behavioral aspect - in this case the performance of tactile stimulation.

Study population: Infants born before 32 weeks of gestation will be included in this trial.

Intervention: At the start of the study, each participating centre will perform selective tactile stimulation in accordance with international guidelines, as is their usual practice. Clinicians will gently rub the back, chest, extremities or soles of the feet if they consider the breathing of the infant to be insufficient or absent. In the second stage of the study, centres will be randomised to switch their stimulation approach to repetitive stimulation. Clinicians will then gently rub the back, chest, extremities or soles of the feet for 10 seconds. To avoid extinction of the stimulatory effect (reflex), every 10 second period of stimulation will be followed by 10 seconds of rest (no stimulation). Repetitive stimulation will be performed for the first 5 minutes of life, or longer if the breathing is still considered insufficient or absent.

Main study parameter: The proportion of infants with pre-ductal oxygen saturation (SpO2) ≥ 80%.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3280 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This is a stepped-wedge cluster randomised controlled trial. The participating centre, rather than the individual infant, will be the unit of randomisation.This is a stepped-wedge cluster randomised controlled trial. The participating centre, rather than the individual infant, will be the unit of randomisation.
Masking:
Single (Outcomes Assessor)
Masking Description:
Centres will be randomised for the fortnight at which they will switch their tactile stimulation practice from selective stimulation to repetitive stimulation. The analysing researcher will be blinded for the allocation of treatment switch.
Primary Purpose:
Treatment
Official Title:
A Randomised Trial of Repetitive Versus Selective Tactile Stimulation for Preterm Infants at Birth: The NEU-STIM Trial
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Selective stimulation

At the start of the study, selective tactile stimulation will be performed at each participating centre in accordance with international guidelines. Clinicians will gently rub the back, chest, extremities or soles of the feet if they consider the breathing of the infant to be insufficient or absent. All other procedures in the delivery room and NICU will be performed according to international and local guidelines.

Procedure: Selective tactile stimulation
See arm

Experimental: Repeated stimulation

For each centre, a lot will be drawn which indicates the month in which the protocol for tactile stimulation changes from selective stimulation to repetitive stimulation. Repetitive stimulation is defined as gently rubbing the soles of the feet, back, chest, or extremities for 10 seconds. To prevent extinction of the stimulatory effect (reflex), every 10 second period of stimulation will be followed by 10 seconds rest (no stimulation). The repetitive stimulation will be performed for the first 5 minutes after birth, or longer if the breathing is still considered insufficient or absent. All other procedures in the delivery room and NICU will be performed according to international and local guidelines.

Procedure: Repeated tactile stimulation
See arm

Outcome Measures

Primary Outcome Measures

  1. SpO2>80 [At 5 minutes of life]

    Proportion of infants with pre-ductal SpO2 >80%

Secondary Outcome Measures

  1. Heart rate [At 5 minutes after birth]

    Heart rate

  2. Number of infants who received CPAP <10min [Within 10 minutes after birth]

    Number of infants who received continuous positive airway pressure

  3. Number of infants who received PPV <10min [Within 10 minutes after birth]

    Number of infants who received positive pressure ventilation

  4. Number of infants who were intubated <10min [Within 10 minutes after birth]

    Number of infants who were endotracheally intubated

  5. Number of infants who received chest compressions <10min [Within 10 minutes after birth]

  6. Number of infants who were administered adrenaline <10min [Within 10 minutes after birth]

    Adrenaline use

  7. Number of infants who were administered volume expansion <10min [Within 10 minutes after birth]

  8. Max FiO2 [In the first 10 minutes after birth]

    Maximum FiO2

  9. Death <10min [Within 10 minutes after birth]

  10. Number of infants who were supported by CPAP in first week [In the first week after birth]

    CPAP use in the NICU

  11. Number of infants who received surfactant in first week [In the first week after birth]

    Surfactant administration via INSURE, LISA or ET tube

  12. Surfactant doses [In the first week after birth]

    Number of surfactant doses administered

  13. Number of infants who were mechanically ventilated >12h [In the first week after birth]

    Mechanical ventilation for more than 12hours

  14. Number of infants with abnormalities on the first cranial ultrasound [In first week after birth]

    Abnormalities on first cranial ultrasound (IVH/PVL)

  15. Death [In the first week after birth]

    Mortality

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 32 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Infants born before 32 weeks of gestation can be included in this trial after parental consent.
Exclusion Criteria:
  • Infants will be excluded if they are found to have a congenital abnormality or condition that has an adverse effect on breathing/ventilation or oxygenation, including: congenital diaphragmatic hernia, trachea-oesophageal fistula, cyanotic heart disease and surfactant protein deficiency. Many of the infants enrolled in the study will later be diagnosed with respiratory distress syndrome (RDS); this will not render them ineligible for inclusion.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of Graz Graz Austria 8036
2 Clinical Hospital Center Rijeka Rijeka Croatia 51000
3 National Maternity Hospital Dublin Ireland D02 YH21
4 Leiden University Medical Center Leiden Zuid-Holland Netherlands 2333ZA
5 La Fe University Hospital Valencia Spain 46026

Sponsors and Collaborators

  • Leiden University Medical Center
  • European Society for Paediatric Research

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Janneke Dekker, Principal Investigator, Leiden University Medical Center
ClinicalTrials.gov Identifier:
NCT05942924
Other Study ID Numbers:
  • N22.121
First Posted:
Jul 12, 2023
Last Update Posted:
Jul 12, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Janneke Dekker, Principal Investigator, Leiden University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 12, 2023